日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

BAG2, MAD2L1, and MDK are cancer-driver genes and candidate targets for novel therapies in malignant pleural mesothelioma

BAG2、MAD2L1 和 MDK 是癌症驱动基因,也是恶性胸膜间皮瘤新型疗法的候选靶点。

Luisa Bisceglia # ,Federica Morani # ,Lara Guerrieri ,Eric Santoni-Rugiu ,Pınar Çakılkaya ,Cristian Scatena ,Rosa Scarpitta ,Lars H Engelholm ,Niels Behrendt ,Federica Gemignani ,Stefano Landi

A rare case report of a primary lung cancer comprising adenocarcinoma and atypical carcinoid tumor, with the carcinoid component harboring EML4-ALK rearrangement

一例罕见病例报告,报告了一种由腺癌和非典型类癌组成的原发性肺癌,其中类癌成分含有 EML4-ALK 重排

Wenbin Hu, Jiaming Zhao, Guoxia Wang, Qihao Wang, Mingming Deng, Jie Shen, Paul Hofman, Edyta Maria Urbanska, Eric Santoni-Rugiu, Petros Christopoulos, Robert A Ramirez, Toyoaki Hida, Xiaoqing Lu, Binjun He

Polyclonal lymphoid expansion drives paraneoplastic autoimmunity in neuroblastoma

多克隆淋巴样扩增驱动神经母细胞瘤的副肿瘤自身免疫

Miriam I Rosenberg, Erez Greenstein, Martin Buchkovich, Ayelet Peres, Eric Santoni-Rugiu, Lei Yang, Martin Mikl, Zalman Vaksman, David L Gibbs, Dan Reshef, Amy Salovin, Meredith S Irwin, Arlene Naranjo, Igor Ulitsky, Pedro A de Alarcon, Katherine K Matthay, Victor Weigman, Gur Yaari, Jessica A Panze

The Collagen Receptor uPARAP in Malignant Mesothelioma: A Potential Diagnostic Marker and Therapeutic Target

恶性间皮瘤中的胶原受体 uPARAP:潜在的诊断标记和治疗靶点

Pınar Çakılkaya, Rikke Raagaard Sørensen, Henrik Jessen Jürgensen, Oliver Krigslund, Henrik Gårdsvoll, Christoffer F Nielsen, Eric Santoni-Rugiu, Niels Behrendt, Lars H Engelholm

CRISPR/Cas9 Engineering of Adult Mouse Liver Demonstrates That the Dnajb1-Prkaca Gene Fusion Is Sufficient to Induce Tumors Resembling Fibrolamellar Hepatocellular Carcinoma

成年小鼠肝脏的 CRISPR/Cas9 工程表明 Dnajb1-Prkaca 基因融合足以诱发类似纤维板层肝细胞癌的肿瘤

Lars H Engelholm, Anjum Riaz, Denise Serra, Frederik Dagnæs-Hansen, Jens V Johansen, Eric Santoni-Rugiu, Steen H Hansen, Francesco Niola, Morten Frödin

Differences in RRM1 protein expression between diagnostic biopsies and resection specimens, and changes during carboplatin and paclitaxel treatment, in non-small-cell lung cancer

非小细胞肺癌诊断活检与切除标本中 RRM1 蛋白表达的差异以及卡铂和紫杉醇治疗期间的变化

Jan N Jakobsen, Eric Santoni-Rugiu, Jens B Sørensen

Intratumour variation of biomarker expression by immunohistochemistry in resectable non-small cell lung cancer

可切除非小细胞肺癌中免疫组织化学检测生物标志物表达的肿瘤内变化

Jan Nyrop Jakobsen, Eric Santoni-Rugiu, Jesper Ravn, Jens Benn Sørensen

Loss of miR-10a activates lpo and collaborates with activated Wnt signaling in inducing intestinal neoplasia in female mice

miR-10a 缺失可激活 lpo 并与激活的 Wnt 信号协同诱发雌性小鼠肠道肿瘤

Gustavo Stadthagen, Disa Tehler, Nina Molin Høyland-Kroghsbo, Jiayu Wen, Anders Krogh, Klaus T Jensen, Eric Santoni-Rugiu, Lars H Engelholm, Anders H Lund

The diagnostic value of immunohistochemically detected methylthioadenosine phosphorylase deficiency in malignant pleural mesotheliomas

免疫组化检测甲硫腺苷磷酸化酶缺陷对恶性胸膜间皮瘤的诊断价值

Zarah Glad Zimling, Anne Jørgensen, Eric Santoni-Rugiu

No effect of NGAL/lipocalin-2 on aggressiveness of cancer in the MMTV-PyMT/FVB/N mouse model for breast cancer

NGAL/lipocalin-2 对 MMTV-PyMT/FVB/N 小鼠乳腺癌模型中的癌症侵袭性没有影响

Elisabeth P Cramer, Andreas Glenthøj, Mattias Häger, Anna Juncker-Jensen, Lars H Engelholm, Eric Santoni-Rugiu, Leif R Lund, Ole D Laerum, Jack B Cowland, Niels Borregaard